Tencent, Guoxin co-lead $97m Series E round in Chinese biopharma Evopoint

Tencent Investment and Guoxin Investment have jointly led a Series E funding round of 700 million yuan ($97.4 million) in Evopoint Biosciences.

Related Keywords

Shanghai ,China ,Australia ,Jinan ,Shandong ,Singapore ,Chinese ,Evopoint Biosciences ,Jinan Industrial Development Investment Group , ,Tencent Investment ,Guoxin Investment ,Yuekai Securitie ,Yuekai Capital Investment ,Stars Capital ,Shanghai Pudong Venture ,Loyal Valley Capital ,Oceanpine Capital ,